An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...
Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果